Creutzfeldt-Jakob Disease pathophysiology in adults
Creutzfeldt-Jakob Disease (CJD) is a rare, progressive neurodegenerative disorder classified among transmissible spongiform encephalopathies (TSEs). Its pathophysiology involves abnormal protein folding, leading to widespread brain damage. Unlike infectious agents such as bacteria or viruses, CJD is caused by misfolded prion proteins, which are infectious proteins capable of inducing conformational changes in normal proteins, perpetuating a cycle of neurodegeneration.
In healthy individuals, prion proteins (PrP^C) are predominantly found on cell surfaces, particularly in neural tissue, where they are believed to play roles in cell signaling and protection. In CJD, these proteins undergo a conformational transformation into a pathogenic isoform (PrP^Sc). This misfolded form has a beta-sheet-rich structure that is resistant to proteolytic degradation, enabling it to accumulate within the brain tissue. The accumulation of PrP^Sc leads to the formation of amyloid plaques and spongiform changes within the brain, characteristic of the disease.
The process begins with the initial misfolding of the normal prion protein, which can be sporadic, genetic, or acquired through infection. In sporadic CJD, the exact trigger remains unknown, but it is believed to involve spontaneous conformational change. Genetic cases are associated with mutations in the PRNP gene, influencing the propensity of PrP^C to misfold. Acquired cases result from exposure to prions through contaminated medical instruments, transfusions, or ingestion of infected tissue.
Once misfolded, PrP^Sc acts as a template, inducing the misfolding of additional PrP^C molecules. This chain reaction results in exponential accumulation within neurons and extracellular spaces. The accumulation causes neuronal dysfunction and death through several mechanisms, including oxidative stress, excitotoxicity, and disruption of cellular homeostasis. The ensuing neuronal loss manifests clinically as rapidly progressive dementia, ataxia, myoclonus, visual disturbances, and behavioral changes.
The spread of PrP^Sc within the central nervous system (CNS) is believed to occur via synaptic pathways, leading to widespread neurodegeneration. Microglial activation and astrocytosis also contribute to neuroinflammation, exacerbating neuronal injury. The characteristic spongiform appearance of affected brain tissue results from vacuolation—large, clear vacuoles within the neuropil—further impairing neural function.
Diagnosis of CJD involves clinical assessment, neuroimaging, and laboratory tests, including detection of characteristic proteins in cerebrospinal fluid (such as 14-3-3 protein) and electroencephalogram (EEG) findings. Confirmatory diagnosis often relies on brain biopsy or post-mortem examination revealing spongiform changes, amyloid plaques, and PrP^Sc deposition.
There is currently no effective treatment to halt or reverse the disease process, and CJD remains uniformly fatal, with most patients succumbing within a year of symptom onset. Understanding its pathophysiology underscores the importance of infection control and ongoing research into therapeutic strategies that might interfere with prion propagation or neurodegeneration.
